Page 10 - GTM-3-3

Global Translational Medicine Cardiac regenerative therapy using iPSCs

References J. 2008;72(Suppl A):A49-A55.

1. Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA doi: 10.1253/circj.cj-08-0378.
guideline for the management of heart failure: A report of 4. Takahashi K, Yamanaka S. Induction of pluripotent stem
the American College of Cardiology Foundation/American cells from mouse embryonic and adult fibroblast cultures by
Heart Association Task Force on practice guidelines. defined factors. Cell. 2006;126:663-676.
Circulation. 2013;128:e240-e327.
doi: 10.1016/j.cell.2006.07.024
doi: 10.1016/j.jacc.2013.05.019
5. Silver SE, Barrs RW, Mei Y. Transplantation of human
2. He L, Zhou B. Cardiomyocyte proliferation: Remove brakes pluripotent stem cell-derived cardiomyocytes for cardiac
and push accelerators. Cell Res. 2017;27:959-960. regenerative therapy. Front Cardiovasc Med. 2021;
doi: 10.1038/cr.2017.91 8:707890.
3. Yuasa S, Fukuda K. Cardiac regenerative medicine. Circ doi: 10.3389/fcvm.2021.707890

Volume 3 Issue 3 (2024) 2 doi: 10.36922/gtm.3586